227 related articles for article (PubMed ID: 6786819)
41. Clinical significance of circulating immune complexes. Effect of plasmapheresis.
Hollán SR
Haematologia (Budap); 1978-1979; 12(1-4):69-83. PubMed ID: 395044
[No Abstract] [Full Text] [Related]
42. Therapeutic plasmapheresis by continuous flow cnetrifugation.
Blacklock HA; Hill RS; Bridle M; Simpson IJ; Matthews JR; Woodfield DG
N Z Med J; 1980 Aug; 92(666):145-8. PubMed ID: 6933347
[TBL] [Abstract][Full Text] [Related]
43. Editorial: Plasmapheresis and immunosuppression.
Lancet; 1976 May; 1(7969):1113-4. PubMed ID: 57514
[No Abstract] [Full Text] [Related]
44. Plasma exchange: a selective form of blood-letting.
Isbister JP
Med J Aust; 1979 Aug; 2(4):167-73. PubMed ID: 160005
[TBL] [Abstract][Full Text] [Related]
45. Blood volume and hematocrit value in macroglobulinemia and myeloma.
Kopp WL; MacKinney AA; Wasson G
Arch Intern Med; 1969 Apr; 123(4):394-6. PubMed ID: 4976452
[No Abstract] [Full Text] [Related]
46. [Plasmapheresis--therapeutic aspects].
Wiecek A; Grzeszczak W
Postepy Hig Med Dosw; 1987; 41(2):152-69. PubMed ID: 3313328
[No Abstract] [Full Text] [Related]
47. Plasmapheresis in rheumatic diseases.
Wallace DJ
Biomed Pharmacother; 1986; 40(8):284-6. PubMed ID: 3493039
[TBL] [Abstract][Full Text] [Related]
48. [Plasmapheresis and plasma exchange. Therapeutic indications and risks].
Fernández García J
Rev Clin Esp; 1985 Jun; 177(2):47-52. PubMed ID: 3901155
[No Abstract] [Full Text] [Related]
49. Plasmapheresis: population, parameters, standards.
Rollins J
Prog Clin Biol Res; 1982; 106():397-402. PubMed ID: 7178142
[No Abstract] [Full Text] [Related]
50. [Hematology 2010].
Dreyling M; Subklewe M; Braess J; Spiekermann K
Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1322-5. PubMed ID: 20556691
[No Abstract] [Full Text] [Related]
51. Plasmapheresis in clinical medicine.
Linker C
West J Med; 1983 Jan; 138(1):60-9. PubMed ID: 6601332
[TBL] [Abstract][Full Text] [Related]
52. [Use of plasmapheresis in surgical hematology].
Abdulkadyrov KM; Shatrov VA; Katsadze IuL
Vestn Khir Im I I Grek; 1983 Oct; 131(10):125-8. PubMed ID: 6419431
[TBL] [Abstract][Full Text] [Related]
53. [The treatment of glomerulonephritis (author's transl)].
Thiel G
Ther Umsch; 1982 May; 39(5):341-50. PubMed ID: 7101214
[No Abstract] [Full Text] [Related]
54. [Clinical application and the technical procedure of plasmapheresis].
Gurland HJ; Samtleben W
Internist (Berl); 1983 Jan; 24(1):14-26. PubMed ID: 6341277
[No Abstract] [Full Text] [Related]
55. [Use of plasmapheresis to control anti-Rh antibodies in isoimmunized mothers].
Crespo Cortina M; Arroyo A; Olivares Tinajero G; Manuel Septién J
Ginecol Obstet Mex; 1972 May; 31(187):485-90. PubMed ID: 4624780
[No Abstract] [Full Text] [Related]
56. [Review. The status of plasmapheresis and apheresis].
Schmitt E; Klinkmann H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):291-309. PubMed ID: 2428704
[TBL] [Abstract][Full Text] [Related]
57. [Clinical cases of primary hyperviscosity syndrome].
Artale F; Cramarossa L; Sergio G; Perego MA
Ric Clin Lab; 1983; 13 Suppl 3():345-7. PubMed ID: 6424222
[TBL] [Abstract][Full Text] [Related]
58. [Experience with plasma exchange: application of an apparatus for plasmapheresis (Haemonetics Model 30) in hyperviscosity syndrome].
Amamiya Y; Baba M; Hisamitsu J; Ito T; Amaki T
Rinsho Ketsueki; 1978 Oct; 19(10):1436-8. PubMed ID: 105174
[No Abstract] [Full Text] [Related]
59. [A case of myasthenia gravis associated with systemic lupus erythematosus and pemphigus erythematosus].
Itoh K; Umehara F; Iwasaki H; Kanda A; Arimura K
Rinsho Shinkeigaku; 1997 Feb; 37(2):111-4. PubMed ID: 9164141
[TBL] [Abstract][Full Text] [Related]
60. Therapeutic management of hematological malignancies in elderly patients. Biological and clinical considerations. Part IV: Multiple myeloma and Waldenström's macroglobulinemia.
Quaglino D; Di Leonardo G; Pasqualoni E; Furia N; Di Simone S
Aging (Milano); 1998 Feb; 10(1):5-12. PubMed ID: 9589746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
